VATS Lobectomy
Cross-source consensus on VATS Lobectomy from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Benefits
Risks & contraindications
Background
Evidence quality
Highlighted claims
- VATS lobectomy is a common surgical approach for operable early-stage NSCLC. — Stereotactic ablative radiotherapy versus video-assisted lobectomy for operable stage I non-small-cell lung cancer: study protocol for an emulated target trial
- Patients must be fit enough to tolerate substantial lung resection to undergo VATS lobectomy. — Stereotactic ablative radiotherapy versus video-assisted lobectomy for operable stage I non-small-cell lung cancer: study protocol for an emulated target trial
- VATS use has increased as early-stage NSCLC treatment has moved away from open thoracotomy. — Stereotactic ablative radiotherapy versus video-assisted lobectomy for operable stage I non-small-cell lung cancer: study protocol for an emulated target trial
- Hospital volume is treated as a confounder partly because VATS performance depends on a steep learning curve. — Stereotactic ablative radiotherapy versus video-assisted lobectomy for operable stage I non-small-cell lung cancer: study protocol for an emulated target trial
- VATS is associated with fewer postoperative complications, shorter hospital stays, less pain, and possible long-term survival improvement. — Stereotactic ablative radiotherapy versus video-assisted lobectomy for operable stage I non-small-cell lung cancer: study protocol for an emulated target trial